BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 7474126)

  • 21. Lymphocyte-tropic simian immunodeficiency virus causes persistent infection in the brains of rhesus monkeys.
    Stephens EB; Liu ZQ; Zhu GW; Adany I; Joag SV; Foresman L; Berman NE; Narayan O
    Virology; 1995 Nov; 213(2):600-14. PubMed ID: 7491784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239.
    Miller CJ; McChesney MB; Lü X; Dailey PJ; Chutkowski C; Lu D; Brosio P; Roberts B; Lu Y
    J Virol; 1997 Mar; 71(3):1911-21. PubMed ID: 9032322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a neutralization-escape variant of SHIVKU-1, a virus that causes acquired immune deficiency syndrome in pig-tailed macaques.
    Narayan SV; Mukherjee S; Jia F; Li Z; Wang C; Foresman L; McCormick-Davis C; Stephens EB; Joag SV; Narayan O
    Virology; 1999 Mar; 256(1):54-63. PubMed ID: 10087226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys.
    Burns DP; Collignon C; Desrosiers RC
    J Virol; 1993 Jul; 67(7):4104-13. PubMed ID: 8510218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simian-human immunodeficiency virus containing a human immunodeficiency virus type 1 subtype-E envelope gene: persistent infection, CD4(+) T-cell depletion, and mucosal membrane transmission in macaques.
    Himathongkham S; Halpin NS; Li J; Stout MW; Miller CJ; Luciw PA
    J Virol; 2000 Sep; 74(17):7851-60. PubMed ID: 10933692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergence of a highly pathogenic simian/human immunodeficiency virus in a rhesus macaque treated with anti-CD8 mAb during a primary infection with a nonpathogenic virus.
    Igarashi T; Endo Y; Englund G; Sadjadpour R; Matano T; Buckler C; Buckler-White A; Plishka R; Theodore T; Shibata R; Martin M
    Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14049-54. PubMed ID: 10570196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infection of macaque monkeys with a chimeric human and simian immunodeficiency virus.
    Sakuragi S; Shibata R; Mukai R; Komatsu T; Fukasawa M; Sakai H; Sakuragi J; Kawamura M; Ibuki K; Hayami M
    J Gen Virol; 1992 Nov; 73 ( Pt 11)():2983-7. PubMed ID: 1279105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Characterization of N-linked glycosylation sites on envelope proteins of simian/human immunodeficiency virus in peripheral blood of Chinese rhesus macaques during acute infection].
    Shi Y; Wan YM; Chen J; Wang J; Ren YQ; Wei Q; Cong Z; Xu JQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Oct; 50(10):869-873. PubMed ID: 27686764
    [No Abstract]   [Full Text] [Related]  

  • 29. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
    Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
    J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection of SIVmac-infected macaque monkeys against superinfection by a simian immunodeficiency virus expressing envelope glycoproteins of HIV type 1.
    Dunn CS; Hurtrel B; Beyer C; Gloeckler L; Ledger TN; Moog C; Kieny MP; Mehtali M; Schmitt D; Gut JP; Kirn A; Aubertin AM
    AIDS Res Hum Retroviruses; 1997 Jul; 13(11):913-22. PubMed ID: 9223407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in the extracellular envelope glycoprotein of variants that evolve during the course of simian immunodeficiency virus SIVMne infection affect neutralizing antibody recognition, syncytium formation, and macrophage tropism but not replication, cytopathicity, or CCR-5 coreceptor recognition.
    Rudensey LM; Kimata JT; Long EM; Chackerian B; Overbaugh J
    J Virol; 1998 Jan; 72(1):209-17. PubMed ID: 9420217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus.
    Kumar A; Mukherjee S; Shen J; Buch S; Li Z; Adany I; Liu Z; Zhuge W; Piatak M; Lifson J; McClure H; Narayan O
    Virology; 2002 Sep; 301(2):189-205. PubMed ID: 12359422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus.
    Endo Y; Igarashi T; Nishimura Y; Buckler C; Buckler-White A; Plishka R; Dimitrov DS; Martin MA
    J Virol; 2000 Aug; 74(15):6935-45. PubMed ID: 10888632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques.
    Joag SV; Li Z; Foresman L; Stephens EB; Zhao LJ; Adany I; Pinson DM; McClure HM; Narayan O
    J Virol; 1996 May; 70(5):3189-97. PubMed ID: 8627799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The presence of the casein kinase II phosphorylation sites of Vpu enhances the CD4(+) T cell loss caused by the simian-human immunodeficiency virus SHIV(KU-lbMC33) in pig-tailed macaques.
    Singh DK; Griffin DM; Pacyniak E; Jackson M; Werle MJ; Wisdom B; Sun F; Hout DR; Pinson DM; Gunderson RS; Powers MF; Wong SW; Stephens EB
    Virology; 2003 Sep; 313(2):435-51. PubMed ID: 12954211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consistent patterns of change during the divergence of human immunodeficiency virus type 1 envelope from that of the inoculated virus in simian/human immunodeficiency virus-infected macaques.
    Blay WM; Gnanakaran S; Foley B; Doria-Rose NA; Korber BT; Haigwood NL
    J Virol; 2006 Jan; 80(2):999-1014. PubMed ID: 16379001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infection of baboons with a simian immunodeficiency virus/HIV-1 chimeric virus constructed with an HIV-1 Thai subtype E envelope.
    Klinger JM; Himathongkham S; Legg H; Luciw PA; Barnett SW
    AIDS; 1998 May; 12(8):849-57. PubMed ID: 9631137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SHIV-1157i and passaged progeny viruses encoding R5 HIV-1 clade C env cause AIDS in rhesus monkeys.
    Humbert M; Rasmussen RA; Song R; Ong H; Sharma P; Chenine AL; Kramer VG; Siddappa NB; Xu W; Else JG; Novembre FJ; Strobert E; O'Neil SP; Ruprecht RM
    Retrovirology; 2008 Oct; 5():94. PubMed ID: 18928523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presence of Intact vpu and nef genes in nonpathogenic SHIV is essential for acquisition of pathogenicity of this virus by serial passage in macaques.
    Mackay GA; Niu Y; Liu ZQ; Mukherjee S; Li Z; Adany I; Buch S; Zhuge W; McClure HM; Narayan O; Smith MS
    Virology; 2002 Mar; 295(1):133-46. PubMed ID: 12033772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaginal transmission of chimeric simian/human immunodeficiency viruses in rhesus macaques.
    Lu Y; Brosio P; Lafaile M; Li J; Collman RG; Sodroski J; Miller CJ
    J Virol; 1996 May; 70(5):3045-50. PubMed ID: 8627782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.